Deputy Chief Physician, Gastrointestinal Center Ward 1, Peking University Cancer Hospital. Long-term engagement in minimally invasive surgical diagnosis, treatment, and full-process management of gastrointestinal tumors, with a focus on minimally invasive surgical treatment and perioperative comprehensive management of gastric cancer, gastroesophageal junction cancer, colon cancer, rectal cancer, and gastrointestinal stromal tumors. In terms of surgery, proficient in minimally invasive surgical procedures for tumors ranging from early to locally advanced stages, combined with perioperative pharmacotherapy to optimize patient prognosis. For advanced-stage patients, emphasis is placed on the synergistic application of conversion therapy and surgery to enhance overall treatment outcomes. Regarding potential adverse effects of perioperative pharmacotherapy, dedicated to effective prevention and management of postoperative complications through interdisciplinary collaboration, while also focusing on improving patients' postoperative quality of life, providing comprehensive and personalized diagnostic and treatment services. **Education Background** Undergraduate studies in the eight-year clinical medicine program at Peking University Health Science Center. In 2011, supported by a national scholarship, pursued a doctoral degree in surgery in the Netherlands, focusing on research into postoperative complications of gastrointestinal surgery and their impact on tumor recurrence. After completing the PhD in 2015, returned to China to continue clinical work and scientific research in gastrointestinal tumor surgery, and to promote the standardization of gastrointestinal surgical techniques and safety. **Academic Directions** Focus on the diagnosis, treatment, and research of gastrointestinal tumors, with core directions including: - Mechanistic studies and management strategies for postoperative complications of gastrointestinal tumors; - Evaluation of perioperative pharmacotherapy efficacy and management of adverse effects in gastrointestinal tumors; - Standardized promotion of gastrointestinal surgical techniques and safety under an interdisciplinary collaboration model. **Academic and Research Achievements** As the principal investigator, has led 9 domestic and international research projects, including those funded by the National Natural Science Foundation of China, focusing on perioperative treatment of gastrointestinal tumors and mechanisms of postoperative complications. Has published over 60 SCI papers and applied for 6 invention patents. Has received awards such as Peking University Person of the Year, the International Gastric Cancer Congress Young Investigator Award, and the Best Presentation Award at the Korean International Gastric Cancer Week. Invited as a supervising expert for minimally invasive surgery training by the European Society of Surgical Oncology. As a member of the International Gastric Cancer Association and Deputy Secretary-General of the Surgical Safety and Quality Control Committee of the Chinese Anti-Cancer Association, has participated in numerous domestic and international academic activities in gastrointestinal tumor surgery, delivering over 30 invited lectures at international academic conferences. **Clinical and Teaching Contributions** In the clinical treatment of gastrointestinal tumors, emphasizes precise preoperative multidisciplinary assessment, standardization of surgical procedures, and comprehensive postoperative rehabilitation management, providing precise and personalized treatment plans for patients with gastrointestinal tumors. Actively participates in standardized physician training and international surgical technology exchanges, dedicated to advancing the standardization and safety improvement of gastrointestinal tumor surgical techniques. In recent years, has participated in and led multiple regional and international Continuing Medical Education (CME) activities, offering practical guidance and training in cutting-edge technologies for clinicians.